Association of Fibrate use with clinical expression of hypertrophic cardiomyopathy.

The use of fibrates is associated with a lower incidence of clinical HCM expression. This association was also more prominent in those with obesity, unhealthy metabolic profiles and poor lifestyle behaviours.